Patients with bipolar disorder (BD), schizophrenia, or other psychotic disorders who reported synthetic cannabinoid use at admission to the hospital had shorter length of stay (LOS) and received lower doses of antipsychotics, irrespective of clinical diagnoses, a recent study found. Synthetic cannabinoid products have become popular and have led to an increased number of patients presenting to emergency departments and psychiatric hospitals. The purpose of this study was to evaluate the impact of synthetic cannabinoid use at admission on LOS and doses of antipsychotics at discharge in individuals with BD, schizophrenia, and other psychotic disorders. Researchers retrospectively examined medical records of 324 inpatients admitted from January 2014 to July 2015. They found:
- Synthetic cannabinoid use predicted LOS and antipsychotic dose using structural equation modeling.
- Further, the association of synthetic cannabinoid use with LOS was partly mediated by antipsychotic dose.
- These associations were independent of specific diagnosis.
Deng H, Mohite S, Suchting R, Nielsen DA, Okusaga OO. Impact of synthetic cannabinoid use on hospital stay in patients with bipolar disorder versus schizophrenia, or other psychotic disorders. [Published online ahead of print January 3, 2018]. Psychiatry Res. doi:10.1016/j.psychres.2017.12.089.
This Week's Must Reads
Findings from Survey on Sexual Health and Behavior, Arch Sex Behav; ePub 2018 Apr 25; Levine, et al
Resistance Exercise Reduced Depressive Symptoms, JAMA Psychiatry; ePub 2018 May 9; Gordon, et al
Psychiatric Morbidity Incidence in Military Spouses, Depress Anxiety; ePub 2018 May 10; Steenkamp, et al
Weight Suppression/Elevation in Women 50 and Older, Int J Eat Disord; ePub 2018 Apr 25; Goodman, et al
Early Intervention Backed for Early-phase Psychosis, JAMA Psychiatry; ePub 2018 May 2; Correll, et al
Must Reads in Bipolar Disorder
Social Cognition Status Effect on Bipolar Disorder, J Affect Disord; ePub 2018 Mar 29; Ospina, et al
Lifetime Anxiety History in the Course of BSDs, Psychiatry Res; ePub 2018 Apr 2; Titone, et al
Serious Mental Illness Linked with Violent Behavior, J Interpers Violence; ePub 2018 Mar 13; Roche, et al
BP Disorder Linked with Higher Triglyceride Levels, Bipolar Disord; ePub 2018 Feb 26; Wulsin, et al
Olfactory Processing in Mood Disorders Examined, Bipolar Disord; ePub 2018 Feb 13; Kamath, et al